This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Lexicon Pharmaceuticals(LXRX - Get Report) is a biopharmaceutical company focused on the discovery and development of breakthrough treatments for human disease. This stock,
rated D sell by TheStreet Ratings, is trading up 9.4% to $1.27 in recent trading.
Today's Range: $1.22-$1.30
52-Week Range: $0.81-$2.17
Three-Month Average Volume: 607,792
Shares of LXRX are spiking notably higher today after the company said the combination of LX4211 and the DPP-4 drug reduced blood sugar after meals in type 2 diabetes patients more than DPP-4 inhibitor did on a stand-alone basis.
From a technical standpoint, LXRX is quickly approaching a
breakout trade if this stock can manage to sustain a high-volume move and close above some past overhead resistance levels at $1.32 to $1.44.
Look for a move and close above those levels on volume that's near or above 607,792 shares. If we get that action, then look for LXRX to challenge its August high of $1.85.